Breast cancer deaths among women ages 20-49 declined significantly between 2010 and 2020, according to a new study.

Tempus AI has signed a three-way deal with AstraZeneca and Pathos AI to construct a data-based oncology model that could ...

It’s based on data from cancer registries funded by the US Centers for Disease Control and Prevention and the US National Institutes of Health’s National Cancer Institute, and it’s released ...